NO20014364D0 - Ny cytokin-zalphall-ligand - Google Patents

Ny cytokin-zalphall-ligand

Info

Publication number
NO20014364D0
NO20014364D0 NO20014364A NO20014364A NO20014364D0 NO 20014364 D0 NO20014364 D0 NO 20014364D0 NO 20014364 A NO20014364 A NO 20014364A NO 20014364 A NO20014364 A NO 20014364A NO 20014364 D0 NO20014364 D0 NO 20014364D0
Authority
NO
Norway
Prior art keywords
polypeptide
zalpha11 ligand
new cytokine
cytokine zalpha11
seq
Prior art date
Application number
NO20014364A
Other languages
English (en)
Other versions
NO331551B1 (no
NO20014364L (no
Inventor
Julia E Novak
Scott R Presnell
Cindy A Sprecher
Donald C Foster
Richard D Holly
Jane A Gross
Janet V Johnston
Andrew J Nelson
Stacey R Dillon
Angela K Hammond
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20014364(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO20014364D0 publication Critical patent/NO20014364D0/no
Publication of NO20014364L publication Critical patent/NO20014364L/no
Publication of NO331551B1 publication Critical patent/NO331551B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014364A 1999-03-09 2001-09-07 Isolert cytokin-zalpha11-ligand-polypeptid, isolert polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin NO331551B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26490899A 1999-03-09 1999-03-09
US26599299A 1999-03-11 1999-03-11
US14201399P 1999-07-01 1999-07-01
PCT/US2000/006067 WO2000053761A2 (en) 1999-03-09 2000-03-09 Human cytokine as ligand of the zalpha receptor and uses thereof

Publications (3)

Publication Number Publication Date
NO20014364D0 true NO20014364D0 (no) 2001-09-07
NO20014364L NO20014364L (no) 2001-11-09
NO331551B1 NO331551B1 (no) 2012-01-23

Family

ID=27385745

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20014364A NO331551B1 (no) 1999-03-09 2001-09-07 Isolert cytokin-zalpha11-ligand-polypeptid, isolert polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin
NO20111085A NO20111085L (no) 1999-03-09 2011-07-29 Isolert cytokin-zalphall-ligand-polypeptid, isolert Polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20111085A NO20111085L (no) 1999-03-09 2011-07-29 Isolert cytokin-zalphall-ligand-polypeptid, isolert Polynukleotid, ekspresjonsvektor, dyrket celle, fremgangsmate for fremstilling av peptidet, antistoff som binder til peptidet, anvendelse av preparat omfattende peptidet for fremstilling av medikament for behandling av sykdom, fremgangsmate for pavisning av peptidet i en biologisk prove samt polypeptidet for anvendelse innen medisin

Country Status (23)

Country Link
EP (3) EP1165791B1 (no)
JP (1) JP4405686B2 (no)
KR (1) KR100743640B1 (no)
CN (5) CN1927883B (no)
AT (1) ATE377076T1 (no)
AU (2) AU777842B2 (no)
BR (1) BR0008772B1 (no)
CA (1) CA2366921C (no)
CZ (1) CZ302921B6 (no)
DE (1) DE60036930T2 (no)
DK (1) DK1165791T3 (no)
ES (1) ES2295019T3 (no)
HU (1) HU229148B1 (no)
IL (5) IL145288A0 (no)
MX (1) MXPA01009074A (no)
NO (2) NO331551B1 (no)
NZ (1) NZ514708A (no)
PL (1) PL207350B1 (no)
PT (1) PT1165791E (no)
RU (1) RU2346951C2 (no)
UA (1) UA84387C2 (no)
WO (1) WO2000053761A2 (no)
ZA (1) ZA017370B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
HU229148B1 (en) * 1999-03-09 2013-09-30 Zymogenetics Inc Seattle Human cytokine as ligand of the zalpha receptor and uses thereof
NZ532021A (en) * 2001-10-04 2008-05-30 Genetics Inst Llc Methods and compositions for modulating interleukin-21 receptor activity
CA2465156C (en) * 2001-11-05 2011-10-18 Zymogenetics, Inc. Il-21 antagonists
EP1531850B1 (en) * 2002-06-07 2012-02-22 ZymoGenetics, Inc. Use of IL-21 and monoclonal antibody for treating solid cancers
ZA200500480B (en) 2002-07-15 2006-10-25 Wyeth Corp Methods and compositions for modulating T helper (TH) cell development and function
RU2005113992A (ru) * 2002-10-11 2005-10-27 Ново Нордиск А/С (DK) Лечение аллергических состояний с использованием il-21
JP2006525223A (ja) * 2002-10-11 2006-11-09 ノボ・ノルデイスク・エー／エス Ｉｌ２１の使用によるアレルギー症状の治療
EP1573006B1 (en) * 2002-12-13 2009-11-11 ZymoGenetics, Inc. Il-21 production in prokaryotic hosts
RU2005131852A (ru) 2003-03-14 2006-04-20 Уайт (Us) Антитела против человеческого рецептора il-21 и их применение
US20050124044A1 (en) * 2003-06-19 2005-06-09 Cunningham Mark R. Interleukin-21 analogs
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
ES2359473T3 (es) 2003-07-21 2011-05-23 Transgene S.A. Citoquinas multifuncionales.
JP2007506789A (ja) * 2003-09-25 2007-03-22 ザイモジェネティクス， インコーポレイテッド Ｉｌ−２１を用いた自己免疫疾患の治療方法
US20060228331A1 (en) 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
EP1673387B1 (en) * 2003-10-10 2010-09-15 Novo Nordisk A/S Il-21 derivatives
EP2641611A3 (en) 2003-10-17 2013-12-18 Novo Nordisk A/S Combination therapy
EP1708737A2 (en) * 2004-01-15 2006-10-11 Novo Nordisk A/S Use of interleukin-21 for the treatment of autoimmune diseases and allograft rejection
CA2552043A1 (en) 2004-01-21 2005-08-04 Novo Nordisk A/S Transglutaminase mediated conjugation of peptides
GT200600148A (es) 2005-04-14 2006-11-22 Metodos para el tratamiento y la prevencion de fibrosis
MX2007012887A (es) 2005-04-18 2007-12-10 Novo Nordisk As Variantes il-21.
US20070122413A1 (en) * 2005-11-28 2007-05-31 Sivakumar Pallavur V Il-21 antagonists
AU2007310777A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S IL-21 variants
AU2007336184A1 (en) 2006-12-21 2008-06-26 Novo Nordisk A/S Interleukin-21 variants with altered binding to the IL-21 receptor
DK2217268T3 (en) 2007-12-07 2016-08-15 Zymogenetics Inc MONOCLONAL ANTI-HUMAN IL-21 ANTIBODIES
PE20100141A1 (es) 2008-05-23 2010-02-22 Wyeth Corp Proteina de union al receptor de interleuquina 21
WO2009143526A1 (en) 2008-05-23 2009-11-26 Wyeth Methods of treatment utilizing binding proteins of the interleukin-21 receptor
JP2012504939A (ja) 2008-09-23 2012-03-01 ワイス・エルエルシー 架橋結合タンパク質による活性化シグナルの産生を予測するための方法
CN102021196B (zh) * 2009-11-20 2013-06-26 上海杰隆生物工程股份有限公司 毕赤酵母生产重组人白细胞介素21的方法
CA2877933A1 (en) 2012-06-27 2014-01-03 Yuri Bushkin Rapid assays for t-cell activation by rna measurements using flow cytometry
WO2015110930A1 (en) 2014-01-24 2015-07-30 Pfizer Inc. Modified interleukin 21 receptor proteins
EP2982693A1 (en) * 2014-08-07 2016-02-10 Affimed Therapeutics AG CD3 binding domain
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
CN112662694A (zh) * 2020-12-25 2021-04-16 康九生物科技(长春)有限公司 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK368882A (da) 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
CA1280080C (en) 1984-12-06 1991-02-12 Jacques Oberto Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
DE68926888T2 (de) 1988-01-22 1997-01-09 Zymogenetics Inc Verfahren zur Herstellung von sekretierten Rezeptoranalogen
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
WO1994006463A1 (en) 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
JPH09501055A (ja) 1993-07-30 1997-02-04 ユニバーシティ オブ メディシン アンド デンティストリー オブ ニュージャージー 初代リンパ球への効率的遺伝子転移
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
CA2237039A1 (en) 1995-11-09 1997-05-15 Zymogenetics, Inc. Production of gad65 in methylotrophic yeast
AU708572B2 (en) 1996-07-17 1999-08-05 Zymogenetics Inc. Preparation of (pichia methanolica) auxotrophic mutants
AU718510B2 (en) 1996-07-17 2000-04-13 Zymogenetics Inc. Transformation of pichia methanolica
AU5702298A (en) 1996-12-03 1998-06-29 Abgenix, Inc. Transgenic mammals having human Ig loci including plural VH and VK regions nd antibodies produced therefrom
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US6057128A (en) * 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
HU229148B1 (en) * 1999-03-09 2013-09-30 Zymogenetics Inc Seattle Human cytokine as ligand of the zalpha receptor and uses thereof
US9418201B1 (en) 2015-11-19 2016-08-16 International Business Machines Corporation Integration of functional analysis and common path pessimism removal in static timing analysis

Also Published As

Publication number Publication date
CZ20013184A3 (cs) 2002-04-17
DE60036930T2 (de) 2008-10-09
CN101575377A (zh) 2009-11-11
ZA017370B (en) 2002-06-26
NO331551B1 (no) 2012-01-23
PT1165791E (pt) 2008-01-16
DK1165791T3 (da) 2008-02-11
CA2366921C (en) 2013-12-17
UA84387C2 (ru) 2008-10-27
IL207424A (en) 2013-04-30
CZ302921B6 (cs) 2012-01-18
EP2295577A3 (en) 2012-08-08
IL145288A0 (en) 2002-06-30
MXPA01009074A (es) 2002-03-27
HUP0200418A3 (en) 2003-12-29
NO20014364L (no) 2001-11-09
RU2346951C2 (ru) 2009-02-20
EP1881070B1 (en) 2012-10-03
PL351160A1 (en) 2003-03-24
AU2005200240A1 (en) 2005-02-17
WO2000053761A3 (en) 2000-12-21
CN1927883A (zh) 2007-03-14
BR0008772A (pt) 2002-05-07
DE60036930D1 (de) 2007-12-13
AU3731200A (en) 2000-09-28
CN102406937A (zh) 2012-04-11
ES2295019T3 (es) 2008-04-16
WO2000053761A2 (en) 2000-09-14
KR20010103794A (ko) 2001-11-23
CN1378595A (zh) 2002-11-06
BR0008772B1 (pt) 2011-11-01
IL195713A (en) 2010-11-30
AU777842B2 (en) 2004-11-04
EP1881070A2 (en) 2008-01-23
RU2004126135A (ru) 2006-02-10
IL145288A (en) 2010-11-30
JP2002537839A (ja) 2002-11-12
NZ514708A (en) 2005-01-28
EP2295577A2 (en) 2011-03-16
HUP0200418A2 (hu) 2002-05-29
CA2366921A1 (en) 2000-09-14
CN1827639A (zh) 2006-09-06
CN101575377B (zh) 2012-12-26
NO20111085L (no) 2001-11-09
ATE377076T1 (de) 2007-11-15
EP1165791A2 (en) 2002-01-02
KR100743640B1 (ko) 2007-07-27
CN1927883B (zh) 2011-09-21
JP4405686B2 (ja) 2010-01-27
EP1881070A3 (en) 2008-03-05
IL207403A (en) 2012-03-29
CN100500846C (zh) 2009-06-17
EP1165791B1 (en) 2007-10-31
PL207350B1 (pl) 2010-12-31
HU229148B1 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
NO20014364L (no) Ny cytokin-zalphall-ligand
NO20043419L (no) Nytt cytokin, zcytor17-ligand
TR199501182A2 (tr) Pestisid özellikte yeni proteinler ve suslar.
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
EP0967283A4 (en) GENES CODING FOR PROTEINS WITH TRANSGLYCOLYSTING ACTIVITY.
EP1501936A4 (en) PROTEIN FAMILY OF CYTOKINE
DE69931807D1 (de) Herstellung von ascorbinsäure unter verwendung von hefe
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
DK1001929T3 (da) Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
EP1092773A3 (en) Polypeptide and uses thereof
ES2093596T1 (es) Colesterol oxidasa nueva.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DK0382268T3 (da) Aminocarboxylsyrederivater
NZ606260A (en) Novel polypeptides involved in immune response
DE69632205T2 (de) Herstellung von bacillus thuringiensis integrants
ITRM940091A0 (it) Procedimento per la preparazione di colture cellulari di eisenia foetida (anellidi, oligocheti).

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees